Market Overview

UPDATE: Citigroup Cuts PT to $82 on Thermo Fisher Scientific on In-Line Guidance

Share:
Related TMO
UPDATE: 3D, Thermo Fisher Scientific Partner On National Education Reach
UBS Thinks TMO + PLL Could Create Bio-Production Powerhouse

Citigroup maintained Thermo Fisher Scientific (NYSE: TMO) with a Buy rating and lowered the price target from $83.00 to $82.00.

Citigroup noted, "TMO delivered the 4th strong quarter of the year beating on both the top and bottom line driven by strength in Biopharma (similar with WAT) and Healthcare (flu added +30bps to revs). Academic/Gov't and Industrial remained weak but Applied markets continue to perform well with China demonstrating increased appetite for food safety and air quality systems. 2013 guidance was mostly inline though we believe upside may be possible given TMO's expectation for sequestration (NIH budget down -5%)."

Thermo Fisher Scientific closed at $71.11 on Wednesday.

Latest Ratings for TMO

DateFirmActionFromTo
May 2015JP MorganMaintainsOverweight
May 2015BarclaysMaintainsOverweight
May 2015JefferiesMaintainsBuy

View More Analyst Ratings for TMO
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (TMO)

Around the Web, We're Loving...

Get Benzinga's Newsletters